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thyroid function revealed higher levels of alanine aminotransferase compared 
with patients who have a form of euthyroid autoimmune’s thyroiditis, but with 
no statistically significant difference between the indices (p> 0.05). 
Conclusions. 
1. Autoimmune thyroiditis is often accompanied by the hepatomegaly (in 
76.8 % of cases) as a manifestation of the toxic effects of thyroid stimulating 
hormone in the liver’s parenchyma. 
2. In patients with hypothyroidism, which is complicated for autoimmune 
thyroiditis, there was a significant increase in the level of cholesterol and β- 
lipoproteins in the blood serum, compared with patients with preserved 
function of the thyroid gland. 
3. In patients with autoimmune thyroiditis and primary hypothyroidism in 
76.8 % of cases, an increase in the content of transferases background 
hepatomegaly, which may be considered as its part in the pathological process 
with the development of reactive hepatitis. 
4. The presence of reactive hepatitis and dyslipidemia in patients with 
autoimmune thyroiditis causes the feasibility of additional destination of statins 
and hepatoprotectors plant origin. 
 
 
Shapkin V.E. 
 
APILAC USE IN HYPOTONIC BILIARY DYSKINESIA 
PATIENTS AT THE FAMILY DOCTOR PRACTICE  
 
Kharkiv national medical universit, Kharkiv, Ukraine 
 
     Hypotonic biliary dyskinesia is common nosology in Primary Health Care. 
This pathology seems not very harmful, but it is the basis of such common 
diseases as cholelithiasis, chronic cholecystitis, some forms of chronic hepatitis. 
Increasing the number of hypotonic biliary dyskinesia patients says about the 
lack of effectiveness of conventional therapy, so it is important to elaborate 
new treatment. One of these innovation can be apitherapy that has already 
proved its effectiveness in the treatment of various types of asthenic syndrome 
and arterial hypotension. We are interested in royal jelly preparations that 
combine adequate performance and price.  
     The aim of this study was investigation the efficacy of dry adsorbed royal 
jelly produced by glands of bees ("Apilac") at hypotonic biliary dyskinesia 
patients. The choice of drug was determined by its adaptogenic, tonic, 
biostimulating effects and relatively low price.  
     Materials and methods. We examined hypotonic biliary dyskinesia 
outpatients. There are 63 patient  aged from 18 to 42 years, including 48 
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women (76.2%) and 15 men (23.8%). The diagnosis was determined by clinical 
symptoms, anamnesis data and ultrasound investigation of the hepato-biliary 
system. Apilac administered as monotherapy 2 tablets (20 mg) three times per 
day during 4 weeks.  
     Results. Clinical improvement was observed from 7 - 10 day treatment at the 
majority of patients (42 persons – 66,7%). Next by quantity group consisted of 
17 persons (30.0%), which has been a positive dynamics of clinical symptoms 
from 12 - 20 day treatment. Common symptoms - weakness, fatigue, decreased 
performance, poor sleep decreased or disappeared the first. Appetite improved 
quite early. Dull pain in the right upper quadrant and constipation disappeared a 
little later. Improvement of the status of the hepatobiliary system accompanied 
by the tendency to blood pressure raise in patients with arterial hypotension. 
Positive dynamics took place at the control ultrasound examination of hepato-
biliary system as gallbladder contraction and reduce of bile stagnation. Terms, 
degree and nature of improvements depended on the characteristics of the 
disease and typological features of the patient. Labile nervous system patients 
were most responsible for treatment. Minimal therapeutic effect was observed 
in hypochondriacal syndrome patients. Apilac side effects didn`t occur during 
investigation. 
     Conclusions. Apilac can be recommended for hypotonic biliary 
dyskinesia patients treatment at the general practice - family medicine 
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Condition of the skin, as a leading barrier system of the organism closely 
interrelated to the functional activity of the liver as the main detoxifying and 
biochemical laboratory of the human body. Dermatological symptoms could be 
a manifestation of impaired liver function. Also etiopathogenetic identity of 
skin lesions and liver may occur.  
The most common liver diseases are viral hepatitis. Hepatitis C virus 
affected around 3% of the world population (170-200 million people). Hepatitis 
C virus causes the formation of chronic viral hepatitis C (CVH-C) with 
subsequent a steady progression of the disease. Today CVH-C can be thought 
of a generalized systemic pathological process. The majority of patients with 
CVH-C have latent clinical course of the disease with insignificancy of specific 
"liver" symptoms. At the same time extrahepatic symptoms very often present, 
